SynthesisJournal of the European Academy of Dermatology and Venereology : JEADV2021

Twelve-week secukinumab treatment is consistently efficacious for moderate-to-severe psoriasis regardless of prior biologic and non-biologic systemic treatment: Post hoc analysis of six randomised trials.

P Hampton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.